FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization

Modern Pathology

Volumn 20, Issue 8, 2007, Pages 895-903

  Hafner, Christian ^a   Hartmann, Arndt ^a   Van Oers, Johanna M M ^b   Stoehr, Robert ^a   Zwarthoff, Ellen C ^b   Hofstaedter, Ferdinand ^a   Landthaler, Michael ^a   Vogt, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Acanthosis; bcl 2; FGFR3 mutation; Ki 67; Seborrheic keratosis

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; KI 67 ANTIGEN; PROTEIN BCL 2;

ACANTHOCYTOSIS; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; GENE MUTATION; HEAD AND NECK INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SEBORRHEIC KERATOSIS; SKIN; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL PROLIFERATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, SEBORRHEIC; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RISK FACTORS; SKIN NEOPLASMS;

EID: 34447576555     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800837     Document Type: Article

References (23)

1. Yeatman JM, Kilkenny M, Marks R. The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol 1997;137:411-414.
2. Kwon OS, Hwang EJ, Bae JH, et al Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed 2003;19:73-80.
3. Pierson D, Bandel C, Ehrig T, et al Benign epidermal tumors and proliferations. In: Bolognia JL, Jorizzo JL, Rapini RP (eds). Dermatology. Mosby: New York, 2003, pp 1697-1703.
4. Vun Y, De'Ambrosis B, Spelman L, et al Seborrhoeic keratosis and malignancy: collision tumour or malignant transformation? Australas J Dermatol 2006;47:106-108.
5. Logie A, Dunois-Larde C, Rosty C, et al Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 2005;14:1153-1160.
6. Hafner C, van Oers JM, Hartmann A, et al High frequency of FGFR3 mutations in adenoid seborrheic keratoses. J Invest Dermatol 2006;126:2404-2407.
7. van Oers JM, Lurkin I, van Exsel AJ, et al A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine. Clin Cancer Res 2005;11:7743-7748.
8. Hafner C, van Oers JM, Vogt T, et al Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 2006;116:2201-2207.
9. Erkek E, Bozdogan O, Atasoy P, et al BCL-2-related apoptosis markers in cutaneous human papilloma-virus-associated lesions. Am J Dermatopathol 2004;26:113-118.
10. Hafner C, Vogt T, Hartmann A. FGFR3 mutations in benign skin tumors. Cell Cycle 2006;5:2723-2728.
11. Hafner C, Hartmann A, Real FX, et al Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol 2007, E-pub ahead of print.
12. Cappellen D, De Oliveira C, Ricol D, et al Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet 1999;23:18-20.
13. Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 2000;21:23-39.
14. Passos-Bueno MR, Wilcox WR, Jabs EW, et al Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat 1999;14:115-125.
15. Naski MC, Wang Q, Xu J, et al Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 1996;13:233-237.
16. Rongioletti F, Corbella L, Rebora A. Multiple familial seborrheic keratoses. Dermatologica 1988;176:43-45.
17. Bedi TR. Familial congenital multiple seborrheic verrucae. Arch Dermatol 1977;113:1441-1442.
18. L'Hote CG, Knowles MA. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 2005;304:417-431.
19. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005;16:139-149.
20. Conscience I, Jovenin N, Coissard C, et al P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol 2006;16:518-522.
21. Ko CJ, Shintaku P, Binder SW. Comparison of benign keratoses using p53, bcl-1, and bcl-2. J Cutan Pathol 2005;32:356-359.
22. Gomez-Roman JJ, Saenz P, Molina M, et al Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth. Clin Cancer Res 2005;11:459-465.
23. Onose H, Emoto N, Sugihara H, et al Overexpression of fibroblast growth factor receptor 3 in a human thyroid carcinoma cell line results in overgrowth of the confluent cultures. Eur J Endocrinol 1999;140:s169-s173.